Edge Therapeutics, Inc.·4

Jun 20, 4:15 PM ET

MIDDLEKAUFF W BRADFORD 4

4 · Edge Therapeutics, Inc. · Filed Jun 20, 2018

Insider Transaction Report

Form 4
Period: 2018-06-19
MIDDLEKAUFF W BRADFORD
Senior VP, GC and Secretary
Transactions
  • Award

    Stock Option (Right To Purchase)

    2018-06-19+99,53499,534 total
    Exercise: $1.10Common Stock (99,534 underlying)
Footnotes (2)
  • [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
  • [F2]These options expire on the third anniversary of the vesting date.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT